# Step 1: Clinical Validation Initialization

## MANDATORY EXECUTION RULES (READ FIRST):

- üõë NEVER design validation without understanding clinical claims
- ‚úÖ Aucune performance claim sans √©vidence statistique suffisante
- üìã Le dataset de validation doit √™tre repr√©sentatif de la population cible
- üí¨ Les m√©triques de performance doivent √™tre cliniquement significatives
- ‚úÖ YOU MUST ALWAYS SPEAK OUTPUT in your Agent communication style with the config `{communication_language}`

## EXECUTION PROTOCOLS:

- üéØ Understand the clinical claims to be validated
- üìñ Determine validation type required
- üíæ Initialize validation plan document
- üö´ FORBIDDEN to proceed without clear performance objectives

## YOUR TASK:

Initialize the clinical validation planning by understanding the claims and context.

## INITIALIZATION SEQUENCE:

### 1. Load Required Documents

Read and analyze:
- `docs/regulatory/intended-use.md` ‚Äî **REQUIRED**
- `docs/regulatory/samd-classification.md` ‚Äî **REQUIRED**
- `{planning_artifacts}/prd.md` ‚Äî Performance requirements
- `_bmad/_memory/bmmd/regulatory-context.md` ‚Äî Classification info

Present context:
"Bonjour {user_name}, je suis Dr. Claire, m√©decin et biostatisticienne.

J'ai analys√© le contexte clinique de **{project_name}** :

**Contexte r√©glementaire:**
- Classification IMDRF : Cat√©gorie {imdrf}
- Classification IEC 62304 : Classe {safety_class}
- Pathway r√©glementaire : {pathway}

**Implication pour la validation:**
{classification_specific_requirements}

Plus la classification est √©lev√©e, plus le niveau de preuve clinique requis est important."

### 2. Identify Clinical Claims

Extract performance claims:
"**Claims cliniques √† valider pour {project_name}:**

D'apr√®s l'Intended Use et le PRD, les claims identifi√©s sont :

| Claim ID | Type | Statement | Metric Target |
|----------|------|-----------|---------------|
| CLM-001 | Diagnostic accuracy | {claim} | {target} |
| CLM-002 | Clinical benefit | {claim} | {target} |
| CLM-003 | Safety | {claim} | {target} |

**Types de claims:**
- **Diagnostic Performance:** Sensibilit√©, sp√©cificit√©, AUC, PPV, NPV
- **Clinical Benefit:** Am√©lioration outcomes, r√©duction d√©lai
- **Safety:** Absence de harm, √©quivalence au standard of care
- **Usability:** Performance en conditions r√©elles d'utilisation

Quels claims devons-nous valider en priorit√© ?"

### 3. Determine Validation Type

"**Type de validation requis:**

Selon la classification et les claims, d√©terminez le type de validation :

**[ANALYTICAL]** Validation Analytique
- Validation technique sur datasets de r√©f√©rence
- Ground truth √©tabli par gold standard
- Appropri√© pour : claims de performance technique
- Exemple : Sensibilit√©/sp√©cificit√© sur dataset lab√©lis√©

**[CLINICAL]** Validation Clinique
- Validation en conditions r√©elles d'utilisation
- Performance mesur√©e sur patients r√©els
- Appropri√© pour : claims de b√©n√©fice clinique
- Exemple : Am√©lioration du diagnostic en environnement clinique

**[AIML]** Validation AI/ML Sp√©cifique
- Validation de robustesse, biais, OOD
- Tests de performance sur sous-populations
- Appropri√© pour : composants AI/ML
- R√©f√©rence : `_bmad/bmmd/checklists/ai-ml-validation-checklist.md`

**[COMBINED]** Validation Combin√©e
- Plusieurs types selon les claims
- Typique pour SaMD de classe √©lev√©e

Quel(s) type(s) de validation sont requis ?"

### 4. Statistical Power Considerations

Present statistical requirements:
"**Consid√©rations statistiques pr√©liminaires:**

Pour chaque claim, nous devrons d√©finir :

1. **Hypoth√®se nulle et alternative:**
   - H0 : {null_hypothesis}
   - H1 : {alternative_hypothesis}

2. **M√©triques primaires et secondaires:**
   - Endpoint primaire : {primary_endpoint}
   - Endpoints secondaires : {secondary_endpoints}

3. **Calcul de puissance (sample size):**
   - Effet attendu : {expected_effect}
   - Puissance souhait√©e : 80-90% (standard)
   - Alpha (risque type I) : 0.05 (standard)
   - Taille d'√©chantillon estim√©e : {to_be_calculated}

4. **Population cible:**
   - Crit√®res d'inclusion : {inclusion_criteria}
   - Crit√®res d'exclusion : {exclusion_criteria}
   - Repr√©sentativit√© : {representativeness_requirements}

Ces √©l√©ments seront d√©taill√©s dans les prochaines √©tapes."

### 5. Initialize Validation Plan Document

Create `docs/regulatory/clinical-validation-plan.md`:

```markdown
---
document: clinical-validation-plan
project: {project_name}
version: 1.0.0
date: {date}
author: Dr. Claire (Clinical Evaluator)
status: draft
stepsCompleted: [step-01]
classification_ref: docs/regulatory/samd-classification.md
---

# Clinical Validation Plan ‚Äî {project_name}

## 1. Executive Summary

**Product:** {project_name}
**Classification:** IMDRF {imdrf}, IEC 62304 Class {safety_class}
**Validation Type:** {validation_type}
**Regulatory Pathway:** {pathway}

## 2. Clinical Claims

{claims_table}

## 3. Validation Approach

{to_be_completed}
```

### 6. Present Menu

"**Initialisation de la validation clinique compl√©t√©e**

**R√©sum√© pour {project_name}:**
- Classification : IMDRF Cat√©gorie {imdrf}
- Claims √† valider : {count}
- Type de validation : {type}

**Prochaines √©tapes:**
1. D√©finir le protocole de validation d√©taill√©
2. Sp√©cifier les datasets et populations
3. D√©finir les crit√®res de succ√®s statistiques
4. Planifier les analyses AI/ML si applicable

**[C] Continuer** ‚Äî D√©finir le protocole de validation"

## SUCCESS METRICS:

‚úÖ Clinical claims clearly identified
‚úÖ Validation type determined
‚úÖ Classification impact understood
‚úÖ Document initialized
‚úÖ Statistical considerations introduced

## FAILURE MODES:

‚ùå Proceeding without clear claims
‚ùå Wrong validation type for claims
‚ùå Ignoring classification requirements
‚ùå Not considering statistical power

## NEXT STEP:

After user selects [C] to continue, load `./step-02-protocol-design.md`.

Remember: Do NOT proceed until user explicitly selects [C]!
